propofol + remifentanil + vecuronium

This is a combination of three intravenous agents commonly used in anesthesia practice: - **Propofol** is a short-acting sedative-hypnotic agent that acts as a positive allosteric modulator of the GABA-A receptor, producing sedation and hypnosis. It is widely used for induction and maintenance of general anesthesia due to its rapid onset and recovery profile[3]. - **Remifentanil** is an ultra-short acting synthetic opioid analgesic that acts as a potent agonist at the mu-opioid receptor, providing profound analgesia. Its rapid metabolism allows for precise control during surgical procedures[4][7]. - **Vecuronium** is a nondepolarizing neuromuscular blocking agent (muscle relaxant) that competitively inhibits acetylcholine at nicotinic receptors on the motor endplate, resulting in skeletal muscle relaxation necessary for intubation and surgery[6]. The combination of these three drugs provides hypnosis (propofol), analgesia (remifentanil), and muscle relaxation (vecuronium), which are essential components of balanced general anesthesia. This regimen allows for rapid induction, titratable maintenance, quick recovery after cessation, and optimal conditions for airway management and surgery[1][2]. The drugs are typically administered intravenously via separate infusions or boluses; while propofol-remifentanil mixtures have been studied for convenience in total intravenous anesthesia (TIVA), vecuronium must be given separately due to incompatibility with lipid emulsions like propofol's formulation[1][5].